Literature DB >> 26244528

Abnormal Placentation: Placenta Previa, Vasa Previa, and Placenta Accreta.

Robert M Silver1.   

Abstract

Placental disorders such as placenta previa, placenta accreta, and vasa previa are all associated with vaginal bleeding in the second half of pregnancy. They are also important causes of serious fetal and maternal morbidity and even mortality. Moreover, the rates of previa and accreta are increasing, probably as a result of increasing rates of cesarean delivery, maternal age, and assisted reproductive technology. The routine use of obstetric ultrasonography as well as improving ultrasonographic technology allows for the antenatal diagnosis of these conditions. In turn, antenatal diagnosis facilitates optimal obstetric management. This review emphasizes an evidence-based approach to the clinical management of pregnancies with these conditions as well as highlights important knowledge gaps.

Entities:  

Mesh:

Year:  2015        PMID: 26244528     DOI: 10.1097/AOG.0000000000001005

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  54 in total

1.  Pregnancy, birth, and infant outcomes by maternal fertility status: the Massachusetts Outcomes Study of Assisted Reproductive Technology.

Authors:  Barbara Luke; Daksha Gopal; Howard Cabral; Judy E Stern; Hafsatou Diop
Journal:  Am J Obstet Gynecol       Date:  2017-04-08       Impact factor: 8.661

2.  Surgical management of 58 patients with placenta praevia percreta.

Authors:  Aysun Camuzcuoglu; Mehmet Vural; Nese Gul Hilali; Adnan Incebiyik; Hasan Husnu Yuce; Ahmet Kucuk; Hakan Camuzcuoglu
Journal:  Wien Klin Wochenschr       Date:  2016-02-25       Impact factor: 1.704

3.  Live birth rate of twin pregnancies after frozen embryo transfer: natural cycle versus ovulation induction regimens.

Authors:  Depeng Zhao; Guanglin Zhao; Jing Fan; Haiyan Chen; Enrico Lopriore; Xuemei Li
Journal:  Arch Gynecol Obstet       Date:  2021-03-06       Impact factor: 2.344

4.  Cesarean birth and maternal morbidity among Black women and White women after implementation of a blended payment policy.

Authors:  Jonathan M Snowden; Sarah S Osmundson; Menolly Kaufman; Cori Blauer Peterson; Katy Backes Kozhimannil
Journal:  Health Serv Res       Date:  2020-07-16       Impact factor: 3.402

5.  Prediction of placenta accreta spectrum in patients with placenta previa using clinical risk factors, ultrasound and magnetic resonance imaging findings.

Authors:  Valeria Romeo; Francesco Verde; Laura Sarno; Sonia Migliorini; Mario Petretta; Pier Paolo Mainenti; Maria D'Armiento; Maurizio Guida; Arturo Brunetti; Simone Maurea
Journal:  Radiol Med       Date:  2021-06-22       Impact factor: 3.469

Review 6.  First trimester serum PAPP-A is associated with placenta accreta: a retrospective study.

Authors:  Fengge Wang; Shuxiong Chen; Jishui Wang; Yangping Wang; Fang Ruan; Hua Shu; Liangxi Zhu; Dongmei Man
Journal:  Arch Gynecol Obstet       Date:  2021-01-30       Impact factor: 2.344

7.  A retrospective segmentation analysis of placental volume by magnetic resonance imaging from first trimester to term gestation.

Authors:  Rachel L León; Kevin T Li; Brandon P Brown
Journal:  Pediatr Radiol       Date:  2018-07-20

8.  Intrauterine Inflated Foley's Catheter Balloon in the Management of Abnormally Invasive Placenta Previa: A Case-Control Study.

Authors:  Mahmoud Thabet; Mohamed Sayed Abdelhafez; Emad Ahmed Fyala
Journal:  J Obstet Gynaecol India       Date:  2017-05-04

9.  Maternal and Neonatal Outcomes of Placenta Previa with and without Coverage of a Uterine Scar: A Retrospective Cohort Study in a Tertiary Hospital.

Authors:  Jiaming Rao; Dazhi Fan; Zixing Zhou; Xin Luo; Huiting Ma; Yingchun Wan; Xiuyin Shen; Dongxin Lin; Huishan Zhang; Yan Liu; Zhengping Liu
Journal:  Int J Womens Health       Date:  2021-07-06

Review 10.  Pregnancy-Related Hysterectomy for Peripartum Hemorrhage: A Literature Narrative Review of the Diagnosis, Management, and Techniques.

Authors:  Dimitrios Tsolakidis; Dimitrios Zouzoulas; George Pados
Journal:  Biomed Res Int       Date:  2021-07-06       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.